Hepatocellular carcinoma: Clinical-pathological features and HIV infection in Mozambican patients<sup/> [0.03%]
莫桑比克肝细胞癌患者临床病理特征及艾滋病感染状况
Lina Cunha,Carla Carrilho,Nilesh Bhatt et al.
Lina Cunha et al.
Background and aims: Mozambique had been ranked among the countries with the highest global incidence of HCC with chronic hepatitis B infection and high exposure to aflatoxin-B1 (AFB1) being major risk factors. Indeed, HC...
Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib [0.03%]
立体放射外科治疗厄洛替尼寡进展患者的II期研究
Jared Weiss,Brian Kavanagh,Allison Deal et al.
Jared Weiss et al.
Introduction: Retrospective studies have evaluated the approach of stereotactic radiotherapy (SRT) to address oligoprogression in patients with EGFR mutant NSCLC on TKI therapy, it has never been prospectively studied. ...
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience [0.03%]
寡进展和寡复发尿路上皮癌患者的立体定向放疗：一项回顾性研究经验报告
G Francolini,I Desideri,B Detti et al.
G Francolini et al.
Urothelial cancer is one of the most common malignancies; after relapse or disease progression available therapeutic options are limited. We analyze efficacy and toxicity of local treatment on metastases using stereotactic body radiation th...
The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1) [0.03%]
中国晚期乳腺癌患者中雌激素受体1基因突变的流行病学调查：雌激素受体研究（EROS1）
Omar Najim,Manon Huizing,Konstantinos Papadimitriou et al.
Omar Najim et al.
Background: Breast cancer has, due its high incidence, the highest mortality of cancer in women. The most common molecular variety of breast cancer is luminal subtype that expresses estrogen and progesterone receptors. Es...
De-novo metastatic breast cancers with or without primary tumor resection - A 10-year study [0.03%]
无原发肿瘤切除的乳腺癌新转移灶的十年研究
Michael Co,Judy Ng,Ava Kwong
Michael Co
Background: Treatment of de novo metastatic breast cancer is usually palliative with systemic treatment; surgical excision of the primary tumour is reserved in patients with significant symptoms from the primary tumour. S...
Showkat Ahmad Bhat,Sabhiya Majid,Hilal Ahmad Wani et al.
Showkat Ahmad Bhat et al.
Epigenetic alterations are clearly involved in cancer initiation and progression as recent epigenetic studies of genomic DNA, histone modifications and micro-RNA alterations suggest that these are playing an important role in the incidence ...
Treatment patterns, clinical outcomes, health resource utilization, and cost in patients with BRCA-mutated metastatic breast cancer treated in community oncology settings [0.03%]
BRCA突变转移性乳腺癌社区肿瘤治疗模式、临床结局、卫生资源利用和费用
Arthur C Houts,Tope Olufade,Rahul Shenolikar et al.
Arthur C Houts et al.
Purpose: This retrospective study of community oncology patients with breast cancer gene (BRCA)-mutated metastatic breast cancer (MBC) examined treatment outcomes and health resource utilization (HRU) and costs for a samp...
Observational Study
Cancer treatment and research communications. 2019:19:100121. DOI:10.1016/j.ctarc.2019.100121 2019
Is human papillomavirus associated with breast cancer or papilloma presenting with pathologic nipple discharge? [0.03%]
人乳头瘤病毒与病理性的乳头分泌物有关吗？
Fatih Levent Balci,Cihan Uras,Sheldon Marc Feldman
Fatih Levent Balci
Purpose: There are little data on the presence or interaction of human papillomavirus (HPV) in intraductal papilloma or Breast cancer (BC) presenting with pathologic nipple discharge (PND). The study aimed to determine wh...
Initial results of a randomized phase III trial of high dose image guided radiation with or without androgen deprivation therapy for intermediate-risk prostate cancer [0.03%]
高剂量影像引导放疗联合或不联合去势治疗中危前列腺癌的III期随机对照试验初步结果
Carlos E Vargas,Now Bahar Alam,Mitchell Terk et al.
Carlos E Vargas et al.
Background: Prior randomized studies have shown a survival benefit using combined androgen deprivation therapy (ADT) and radiation therapy for intermediate-risk prostate cancer. However, these studies either used low dose...
Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time [0.03%]
转移性前列腺癌患者在治疗过程中的循环肿瘤DNA(ctDNA)的基因组谱动态变化特征分析
Andrew W Hahn,David Stenehjem,Roberto Nussenzveig et al.
Andrew W Hahn et al.
Background: Targeted therapies have shown promise for men with metastatic castration-resistant prostate cancer (mCRPC). Due to the difficulty with obtaining tumor tissue in bony metastases, liquid biopsies are a promising...